138 related articles for article (PubMed ID: 34233531)
1. Longer duration of anti-retroviral therapy is associated with decreased risk of human papillomaviruses detection in Kenyan women living with HIV.
Ermel A; Tong Y; Tonui P; Orang'o O; Muthoka K; Wong N; Manai T; Kiptoo S; Loehrer PJ; Brown DR
Int J STD AIDS; 2021 Nov; 32(13):1212-1220. PubMed ID: 34233531
[TBL] [Abstract][Full Text] [Related]
2. Association of plasma aflatoxin with persistent detection of oncogenic human papillomaviruses in cervical samples from Kenyan women enrolled in a longitudinal study.
Tong Y; Tonui P; Orang'o O; Zhang J; Maina T; Muthoka K; Groopman J; Smith J; Madeen E; Ermel A; Loehrer P; Brown DR
BMC Infect Dis; 2023 Jun; 23(1):377. PubMed ID: 37280534
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of high-risk human papillomavirus and cervical lesions in African women living with HIV/AIDS: effect of anti-retroviral therapy.
Kelly HA; Sawadogo B; Chikandiwa A; Segondy M; Gilham C; Lompo O; Omar T; Didelot MN; Nagot N; Meda N; Weiss HA; Delany-Moretlwe S; Mayaud P;
AIDS; 2017 Jan; 31(2):273-285. PubMed ID: 27755107
[TBL] [Abstract][Full Text] [Related]
4. A cross-sectional analysis of factors associated with detection of oncogenic human papillomavirus in human immunodeficiency virus-infected and uninfected Kenyan women.
Ermel A; Tonui P; Titus M; Tong Y; Wong N; Ong'echa J; Muthoka K; Kiptoo S; Moormann A; Hogan J; Mwangi A; Cu-Uvin S; Loehrer PJ; Orang'o O; Brown D
BMC Infect Dis; 2019 Apr; 19(1):352. PubMed ID: 31029097
[TBL] [Abstract][Full Text] [Related]
5. The East Africa Consortium for human papillomavirus and cervical cancer in women living with HIV/AIDS.
Tong Y; Orang'o E; Nakalembe M; Tonui P; Itsura P; Muthoka K; Titus M; Kiptoo S; Mwangi A; Ong'echa J; Tonui R; Odongo B; Mpamani C; Rosen B; Moormann A; Cu-Uvin S; Bailey JA; Oduor CI; Ermel A; Yiannoutsos C; Musick B; Sang E; Ngeresa A; Banturaki G; Kiragga A; Zhang J; Song Y; Chintala S; Katzenellenbogen R; Loehrer P; Brown DR
Ann Med; 2022 Dec; 54(1):1202-1211. PubMed ID: 35521812
[TBL] [Abstract][Full Text] [Related]
6. Comparing Papanicolau smear, visual inspection with acetic acid and human papillomavirus cervical cancer screening methods among HIV-positive women by immune status and antiretroviral therapy.
Chung MH; McKenzie KP; De Vuyst H; Richardson BA; Rana F; Pamnani R; Njoroge JW; Nyongesa-Malava E; Sakr SR; John-Stewart GC; Mugo NR
AIDS; 2013 Nov; 27(18):2909-19. PubMed ID: 23842133
[TBL] [Abstract][Full Text] [Related]
7. The EVVA Cohort Study: Anal and Cervical Type-Specific Human Papillomavirus Prevalence, Persistence, and Cytologic Findings in Women Living With HIV.
de Pokomandy A; Kaufman E; de Castro C; Mayrand MH; Burchell AN; Klein M; Charest L; Auger M; Rodrigues-Coutlée S; Coutlée F;
J Infect Dis; 2017 Aug; 216(4):447-456. PubMed ID: 28931234
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of human papillomavirus infection in HIV-infected women living in French Antilles and French Guiana.
Abel S; Najioullah F; Voluménie JL; Accrombessi L; Carles G; Catherine D; Chiappetta D; Clavel C; Codjo-Sodokine A; El Guedj M; Jean-Marie J; Molinié V; Pierre-François S; Stegmann-Planchard S; Vantilcke V; Vaz T; Nacher M; Cabié A; Césaire R;
PLoS One; 2019; 14(9):e0221334. PubMed ID: 31483832
[TBL] [Abstract][Full Text] [Related]
9. Incident detection of human papillomavirus - a prospective follow-up study among Tanzanian women with a focus on HIV status.
Mchome B; Linde DS; Manongi R; Waldstroem M; Lftner T; Wu C; Mwaisalage J; Rasch V; Kjaer SK
Int J Infect Dis; 2021 Sep; 110():165-170. PubMed ID: 34252573
[TBL] [Abstract][Full Text] [Related]
10. Persistence of oncogenic and non-oncogenic human papillomavirus is associated with human immunodeficiency virus infection in Kenyan women.
Tong Y; Tonui P; Ermel A; Orang'o O; Wong N; Titus M; Kiptoo S; Muthoka K; Loehrer PJ; Brown DR
SAGE Open Med; 2020; 8():2050312120945138. PubMed ID: 32782796
[TBL] [Abstract][Full Text] [Related]
11. Genetic diversity in L1 ORF of human papillomavirus in women with cervical cancer with and without human immunodeficiency virus in Botswana and Kenya.
Tawe L; Choga WT; Paganotti GM; Bareng OT; Ntereke TD; Ramatlho P; Ditshwanelo D; Gaseitsiwe S; Kasvosve I; Ramogola-Masire D; Orang'o OE; Robertson E; Zetola N; Moyo S; Grover S; Ermel AC
BMC Infect Dis; 2022 Jan; 22(1):95. PubMed ID: 35086475
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus sequencing reveals its usefulness for the management of HIV-infected women at risk for developing cervical cancer.
Piyathilake CJ; Kumar R; Crowley MR; Badiga S; Burkholder GA
J Obstet Gynaecol Res; 2021 Jun; 47(6):2185-2195. PubMed ID: 33754434
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and genotype-specific distribution of human papillomavirus in Burundi according to HIV status and urban or rural residence and its implications for control.
Ndizeye Z; Vanden Broeck D; Lebelo RL; Bogers J; Benoy I; Van Geertruyden JP
PLoS One; 2019; 14(6):e0209303. PubMed ID: 31237894
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus prevalence, viral load and pre-cancerous lesions of the cervix in women initiating highly active antiretroviral therapy in South Africa: a cross-sectional study.
Moodley JR; Constant D; Hoffman M; Salimo A; Allan B; Rybicki E; Hitzeroth I; Williamson AL
BMC Cancer; 2009 Aug; 9():275. PubMed ID: 19664216
[TBL] [Abstract][Full Text] [Related]
15. High risk human papillomavirus prevalence and genotype distribution among women infected with HIV in Manaus, Amazonas.
Teixeira MF; Sabidó M; Leturiondo AL; de Oliveira Ferreira C; Torres KL; Benzaken AS
Virol J; 2018 Feb; 15(1):36. PubMed ID: 29454382
[TBL] [Abstract][Full Text] [Related]
16. Sustained viral suppression and higher CD4+ T-cell count reduces the risk of persistent cervical high-risk human papillomavirus infection in HIV-positive women.
Konopnicki D; Manigart Y; Gilles C; Barlow P; de Marchin J; Feoli F; Larsimont D; Delforge M; De Wit S; Clumeck N
J Infect Dis; 2013 Jun; 207(11):1723-9. PubMed ID: 23463709
[TBL] [Abstract][Full Text] [Related]
17. Association of Plasma Aflatoxin With Persistent Detection of Oncogenic Human Papillomaviruses in Cervical Samples From Kenyan Women Enrolled in a Longitudinal Study.
Tong Y; Tonui P; Orang'o O; Zhang J; Maina T; Muthoka K; Groopman J; Smith J; Madeen E; Ermel A; Loehrer P; Brown D
Res Sq; 2023 Jan; ():. PubMed ID: 36747756
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus and abnormal cervical lesions among HIV-infected women in HIV-discordant couples from Kenya.
Guthrie BL; Rositch AF; Cooper JA; Farquhar C; Bosire R; Choi R; Kiarie J; Smith JS
Sex Transm Infect; 2020 Sep; 96(6):457-463. PubMed ID: 31919275
[TBL] [Abstract][Full Text] [Related]
19. HIV-positive women have higher risk of human papilloma virus infection, precancerous lesions, and cervical cancer.
Liu G; Sharma M; Tan N; Barnabas RV
AIDS; 2018 Mar; 32(6):795-808. PubMed ID: 29369827
[TBL] [Abstract][Full Text] [Related]
20. Assessing national cervical cancer screening guidelines: Results from an HIV testing clinic also screening for cervical cancer and HPV in Soweto, South Africa.
Hopkins KL; Jaffer M; Hlongwane KE; Otwombe K; Dietrich J; Cheyip M; Olivier J; Doherty T; Gray GE
PLoS One; 2021; 16(7):e0255124. PubMed ID: 34329334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
